Stock Consolidation Decision (5:1 Ratio) and Correction Notice


  • Stock consolidation decision: merge at a 5:1 ratio, changing par value from KRW 100 to KRW 500 (5 old shares → 1 new share)
  • Total common shares decrease from 27,887,050 to 5,575,074 (corrected from previous 5,577,410)
  • Purpose: stabilize stock price and enhance corporate value by maintaining appropriate number of shares in circulation
  • Schedule: trading halt from 2026.04.14 to 2026.05.14, new shares listing on 2026.05.15
  • Fractional shares to be paid in cash based on closing price on the first listing day
  • This is not a capital reduction (no decrease in capital)
  • Subject to special resolution at shareholders' meeting and may change due to regulatory consultations
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: [Correction of Description] Decision on Stock Consolidation
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: KMPHARMACEUTICAL Co.,Ltd.
  • Receipt: 05-04-2026
  • Under KRX KOSDAQ Market Division